Clinical risk factors for recurrence of myelin oligodendrocyte glycoprotein antibody-associated disease.

Our study suggests that the most common clinical manifestations of MOGAD are diminished visual acuity, limb/facial numbness, and ocular/orbital pain. The onset phenotype consisting of optic neuritis, a history of immune disease, high antibody titers (≥1:100), and high cerebrospinal fluid leukocytes (above 50/mm) suggests a high likelihood of MOGAD recurrence.